GL1X · GenesisL1 explorer

Research workbench

Crystal structure of blue fluorescent protein from metagenomic library in complex with NADPH

Analyse Crystal structure of blue fluorescent protein from metagenomic library in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6J7U
Type
protein
Length
988 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Blue fluorescent protein
EC
1.2.4.4
UniProt
D6NKF4
Ligands
NDP
Pockets
5 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DBlue fluorescent protein (EC 1.2.4.4)protein24747% helix, 15% strandD6NKF4

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110500.850.8670empty
210720.830.84109NDP
310160.830.84106NDP
41540.510.7920empty
51420.480.7821empty

Interfaces

6 interfaces between chains.

  • A–C · 1645 Ų buried · 35 hydrogen bonds · protein-protein
  • B–D · 1640 Ų buried · 28 hydrogen bonds · protein-protein
  • A–D · 1599 Ų buried · 26 hydrogen bonds · protein-protein
  • B–C · 1593 Ų buried · 22 hydrogen bonds · protein-protein
  • A–B · 243 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 6J7U · Crystal structure of blue fluorescent protein from metagenomic library in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.